We were never believers in the Corindus acquisition, fearing that it was too expensive. Healthineers has now booked some €-330m to focus the endeavour’s application area, writing off ~25% of the purchase price.
On the other hand, the operating business is performing well, benefiting from the recovery of geographies, especially China, after the pandemic. it was clear to us that this would not be a good year for Diagnostics for many reasons.
10 May 2023
Negative impacts from Corindus
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Negative impacts from Corindus
We were never believers in the Corindus acquisition, fearing that it was too expensive. Healthineers has now booked some €-330m to focus the endeavour’s application area, writing off ~25% of the purchase price.
On the other hand, the operating business is performing well, benefiting from the recovery of geographies, especially China, after the pandemic. it was clear to us that this would not be a good year for Diagnostics for many reasons.